Table 1.

Demographics and Uveitis Characteristics of the Individuals with Orbital Involvement

Age, Years	Race, Sex, Ethnicity	Duration and Location of Orbital Involvement	Laterality	VA at last FU Right	VA at last FU Left	Other Organs Involved	FU Duration, Months	Ocular Structural Complications
45	BMH	Chronic uveitis, unspecified	U	20/20	LP	Lung, ENT	89	Retinal detachment
48	WFH	Chronic uveitis, anterior	B	20/20	20/20	Lung	6
27	BMNH	Acute uveitis, posterior	B	20/20	20/20		9
70	BFNH	Lacrimal gland	U	20/40	20/25		1
48	WFNH	Chronic uveitis, panuveitis	B	20/15	20/15	Lung, ENT	42
81	WFNH	Chronic uveitis, anterior-intermediate	B	20/150	20/50	CNS	28	CME, glaucoma
53	WFNH	Chronic uveitis, panuveitis	B	20/20	20/40	Lung, heart	89	Glaucoma
57	BFNH	Lacrimal gland	B	20/20	20/20	Lung, skin	36
67	BMNH	Chronic uveitis, posterior	U	20/400	20/20	Lung, GI, CNS	47
36	BFNH	Chronic uveitis, panuveitis	B	CF	HM	Lung, CNS	88	CME
66	WFNH	Chronic uveitis, panuveitis	B	20/70	20/30	Lung, CNS	13	CME
60	BFNH	Chronic uveitis, anterior	B	20/70	20/20	Heart	0
66	WMH	Acute uveitis, anterior	U	20/25	20/60	Lung	17
60	WFNH	Unknown, posterior	U	20/20	20/20	Lung, GI	0	CNV

Abbreviations: B, Black; W, White; F, female; M, male; H, Hispanic; NH, non-Hispanic; U, unilateral; B, bilateral; VA, visual acuity; FU, follow-up; LP, light perception; CF, count fingers; HM, hand motion; ENT, ear nose and throat; CNS, central nervous system; GI, gastrointestinal; CME, cystoid macular edema; CNV, choroidal neovascularization.